Zell | $589,875 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)
Remission Medical | Undisclosed Amount | (Apr 14, 2026)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
Pixel Photonics | $5,880,875 | (Apr 14, 2026)
Critical Loop | $26,000,000 | (Apr 14, 2026)
AIRMO | $5,880,175 | (Apr 14, 2026)
Primepoint | $10,000,000 | (Apr 14, 2026)
Blocks | $6,000,000 | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
Quartzy | $23,000,000 | (Apr 14, 2026)
Citra Space Corporation | $15,000,000 | (Apr 14, 2026)
Flashpass | $4,250,000 | (Apr 14, 2026)